4//SEC Filing
Bayley Matthew D 4
Accession 0001144204-17-062254
CIK 0001138776other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:21 PM ET
Size
5.7 KB
Accession
0001144204-17-062254
Insider Transaction Report
Form 4
Bayley Matthew D
Director
Transactions
- Award
Stock Option (Right to Purchase)
2017-12-04+40,000→ 40,000 totalExercise: $1.25Exp: 2027-12-04→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable in three equal installments (rounded up to the nearest whole share of common stock) on December 4, 2018, December 4, 2019 and December 4, 2020, subject to the reporting person's continued service with the issuer.
Documents
Issuer
Aevi Genomic Medicine, Inc.
CIK 0001138776
Entity typeother
Related Parties
1- filerCIK 0001723040
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:21 PM ET
- Size
- 5.7 KB